ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Healy’s Boxes Packed, When Word Came That She Could Stay

January 29, 1993

New Ultrasound Technique For Hard To Diagnose Cysts

June 29, 2001

ACS Prostate Cancer Screening Guideline Urges Doctor-Patient Informed Decision

March 5, 2010

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

In Brief: OMB Misses Deadline On 1989 Budget, Blames Late Actin On ’88 Money Bill; Raney Heads AACE

January 8, 1988